Volume 24 Number 14
31 July 2022

Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 14, 31 July

Nikova AS, Sioutas G, Karanikas M, Birbilis T.
"Security dilemma": active immunotherapy before versus after radiation therapy alone or chemo-radiotherapy for newly diagnosed glioblastoma.
Folia Med (Plovdiv). 2022 Apr 30;64(2):195-201. doi: 10.3897/folmed.64.e62981. PMID: 35851769. Review.

Chandrasekar G, Bansal VS, Panigrahi M, Kitambi SS.
An overview of targets and therapies for glioblastoma multiforme.
J Cancer Res Ther. 2022 May 4, 2022;18(3):591-598. doi: 10.4103/jcrt.jcrt_1324_21. PMID: 35900527. Review.

Hertler C.
Palliative care implementation in neuro-oncology-Where do we come from, where do we go?
Neurooncol Pract. 2022 May 14;9(4):257-258. doi: 10.1093/nop/npac039. PMID: 35859539. Editorial

Halasz LM, Attia A, Bradfield L, Brat DJ, Kirkpatrick JP, Laack NN, Lalani N, Lebow ES, Liu AK, Niemeier HM, Palmer JD, Peters KB, Sheehan J, Thomas RP, Vora SA, Wahl DR, Weiss SE, Yeboa DN, Zhong J, Shih HA.
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline.
Pract Radiat Oncol. 2022 May 31:S1879-8500(22)00144-8. doi: 10.1016/j.prro.2022.05.004. PMID: 35902341. Guidelines.


Prajapati HP, Kannaujia SK.
A simplified overview of the World Health Organization classification of central nervous system tumors 2021.
Surg Neurol Int. 2022 Jun 17;13:252. doi: 10.25259/SNI_102_2022. PMID: 35855126. Review.

El-Abtah ME, Talati P, Dietrich J, Gerstner ER, Ratai EM.
Magnetic resonance spectroscopic imaging for detecting metabolic changes in glioblastoma after anti-angiogenic therapy-a systematic literature review.
Neurooncol Adv. 2022 Jun 27;4(1):vdac103. doi: 10.1093/noajnl/vdac103. PMID: 35892047. Review.

Alpuim Costa D, Sampaio-Alves M, Netto E, Fernandez G, Oliveira E, Teixeira A, Daniel PM, Bernardo GS, Amaro C.
Hyperbaric Oxygen Therapy as a Complementary Treatment in Glioblastoma-A Scoping Review.
Front Neurol. 2022 Jul 1;13:886603. doi: 10.3389/fneur.2022.886603. PMID: 35847231. Review.

Yue J, Yin C, Chen L, Xu R, Zhao D.
Is There a Role for Temozolomide in Glioma Related Seizures? A Systematic Review.
Neurol India. 2022 Jul 1, 2022;70(3):864-871
. doi: 10.4103/0028-3886.349588? PMID: 35864610. Review.

Di Nunno V, Franceschi E, Tosoni A, Gatto L, Bartolini S, Brandes AA.
Tumor-Associated Microenvironment of Adult Gliomas: A Review.
Front Oncol. 2022 Jul 7;12:891543
. doi: 10.3389/fonc.2022.891543. PMID: 35875065. Review.

Zhang P, Zhang Y, Ji N.
Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions.
Front Immunol. 2022 Jul 7;13:927132
. doi: 10.3389/fimmu.2022.927132. PMID: 35874698. Review.

Morgacheva D, Daks A, Smirnova A, Kim A, Ryzhkova D, Mitrofanova L, Staliarova A, Omelina E, Pindyurin A, Fedorova O, Shuvalov O, Petukhov A, Dinikina Y.
Case Report: Primary Leptomeningeal Medulloblastoma in a Child: Clinical Case Report and Literature Review.
Front Pediatr. 2022 Jul 11;10:925340. doi: 10.3389/fped.2022.925340. PMID: 35899134. Case report(s) and Review.

Ronvaux L, Riva M, Coosemans A, Herzog M, Rommelaere G, Donis N, D'Hondt L, Douxfils J.
Liquid Biopsy in Glioblastoma.
Cancers (Basel). 2022 Jul 13;14(14):3394. doi: 10.3390/cancers14143394. PMID: 35884454. Review.

Moser JC, Salvador E, Deniz K, Swanson K, Tusynski J, Carlson KW, Karanam NK, Patel CB, Story M, Lou E, Hagemann C.
The mechanisms of action of Tumor Treating Fields.
Cancer Res. 2022 Jul 15:CAN-22-0887. doi: 10.1158/0008-5472.CAN-22-0887. PMID: 35839284. Review.

van der Meer PB, Taphoorn MJB, Koekkoek JAF.
Management of epilepsy in brain tumor patients.
Curr Opin Oncol. 2022 Jul 16. doi: 10.1097/CCO.0000000000000876. PMID: 35838207. Review.

Kapoor M, Gupta V.
StatPearls. 2022 Jul 18. NCBI Bookshelf ID: NBK559042. PMID: 32644468. Review.

Zhang K, Yang Y, Zhuang J, Guo G, Chao X, Zhang Z.
Intracranial dissemination of glioblastoma multiforme: a case report and literature review.
J Int Med Res. 2022 Jul 19, 2022;50(7):3000605221112047. doi: 10.1177/03000605221112047. PMID: 35854630. Case report and Review.


Lazow MA, Palmer JD, Fouladi M, Salloum R.
Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management.
Neurotherapeutics. 2022 Jul 20. doi: 10.1007/s13311-022-01273-0. PMID: 35859223. Review

Mendez Valdez MJ, Lu VM, Kim E, Rivas SR, Govindarajan V, Ivan M, Komotar R, Nath A, Heiss JD, Shah AH.
Glioblastoma multiforme in patients with human immunodeficiency virus: an integrated review and analysis.
J Neurooncol. 2022 Jul 20. doi: 10.1007/s11060-022-04095-4. PMID: 35857248. Review and Meta-analysis

McNamara C, Mankad K, Thust S, Dixon L, Limback-Stanic C, D'Arco F, Jacques TS, Löbel U.
2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist.
Neuroradiology. 2022 Jul 22. doi: 10.1007/s00234-022-03008-6. PMID: 35869291. Review

Johnson DR, Giannini C, Vaubel RA, Morris JM, Eckel LJ, Kaufmann TJ, Guerin JB.
A Radiologist's Guide to the 2021 WHO Central Nervous System Tumor Classification: Part I-Key Concepts and the Spectrum of Diffuse Gliomas.
Radiology. 2022 Jul 26;213063. doi: 10.1148/radiol.213063. PMID: 35880978. Review


Zheng H, Yan T, Han Y, Wang Q, Zhang G, Zhang L, Zhu W, Xie L, Guo X.
Nomograms for prognostic risk assessment in glioblastoma multiforme: Applications and limitations.
Clin Genet. 2022 Jul 26
. doi: 10.1111/cge.14200. PMID: 35882630. Review˰ Online access of nomograms.

Zhang M, Liu C, Zhou H, Wang W, Wang L, Shi B, Xue X.
Meta of classical chemotherapy compared with high-dose chemotherapy and autologous stem cell rescue in newly diagnosed medulloblastoma after radiotherapy.
Medicine (Baltimore). 2022 Jul 29;101(30):e29372. doi: 10.1097/MD.0000000000029372? PMID: 35905255. Meta-analysis.